USING SELECTIVE ANTAGONIST OF GLUAMATE RECEPTOR Ro-256981 FOR TARGETED EFFECT ON COGNITIVE FUNCTIONS Russian patent published in 2013 - IPC A61K31/445 A61K31/452 A61P25/28 

Abstract RU 2496495 C2

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to pharmacology and concerns using a selective antagonist of glutamate receptors for having an effect of cognitive functions. That is ensured by introducing Ro-256981 as the selective antagonist of glutamate receptors.

EFFECT: invention provides improving such cognitive functions such as long-term spatial memory storage, preventing memory decay, re-training memory enhancement, memory formation in the new environment.

4 ex, 4 tbl

Similar patents RU2496495C2

Title Year Author Number
PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON 2014
  • Bogachuk Anna Pajzenovna
  • Storozheva Zinaida Ivanovna
  • Zolotarev Jurij Aleksandrovich
  • Kovalev Georgij Ivanovich
  • Azev Vjacheslav Nikolaevich
  • Lipkin Valerij Mikhajlovich
RU2557003C2
NOVEL NUTRACEUTICAL COMPOSITIONS CONTAINING STEVIA EXTRACT OR STEVIA EXTRACT COMPONENTS AND USES THEREOF 2008
  • Fauler Ann
  • Goral'Chik Regina
  • Kilpert Klaus
  • Majne-Mekhan Annis Olivija
  • Moazheri Khasan
  • Mussler Bernd
  • Viss Adrian
RU2519718C2
SUBSTITUTED 2-AMINO-3-SULFONYL-TETRAHYDRO-PYRAZOLO[1,5-a]PYRIDO-PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT RECEPTORS, METHODS OF PRODUCING AND USING SAID COMPOUNDS 2008
  • Ivashchenko Aleksandr Vasil'Evich
  • Kisil' Volodimir Mikhajlovich
  • Savchuk Nikolaj Filippovich
  • Ivashchenko Andrej Aleksandrovich
RU2384581C2
METHOD FOR ASSESSING SPATIAL ORIENTATION AND COGNITIVE DISORDERS IN EXPERIMENTAL ANIMALS 2012
  • Shreder Ol'Ga Vasil'Evna
  • Shreder Ekaterina Dmitrievna
  • Durnev Andrej Dmitrievich
RU2551308C2
ACTIVE SOLUBLE ISOFORMS OF NEUREGULIN, WHICH CARRY POST-TRANSLATION MODIFICATIONS 2008
  • Shrattenkhol'Ts Andre
RU2491955C2
COMBINATION FOR TREATING AND PREVENTING BEHAVIOURAL, MENTAL, COGNITIVE AND NEUROLOGICAL DISORDERS ACCOMPANYING ORGANIC CNS DISEASES 2012
  • Morozova Margarita Alekseevna
  • Beniashvili Allan Gerovich
  • Zapol'Skij Maksim Ehduardovich
RU2493838C1
2-AMINO-4-(4-FLUOROBENZYLAMINO)-1-ETHOXYCARBONYL-AMINOBENZENE AS ACTIVE COMPONENT OF MEDICINAL AGENT FOR PROPHYLAXIS AND TREATMENT OF RESULTS OF ACUTE AND CHRONIC CEREBRAL INSUFFICIENCY AND NEURODEGENERATIVE DISEASES ALSO (VARIANTS) 1996
  • Barch Reni
  • Rostok Angelika
  • Rundfel'Dt Kris
  • Tober Kristina
RU2201227C2
METHOD OF ASSESSING COGNITIVE FUNCTIONS AND MEMORY IMPAIRMENT IN LABORATORY ANIMALS 2022
  • Shreder Olga Vasilevna
RU2808376C1
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND THEIR USE 2019
  • Folkmann, Robert, A.
  • Anderson, Devid, R.
  • Malekiani, Sem
  • Pajzer, Timoti
  • Kini, Gregg, F.
  • Lejzer, Stiven, K.
RU2800064C2
COMBINED DRUG FOR PHARMACORRECTION OF COGNITIVE DYSFUNCTIONS AFTER KETAMINE ANESTHESIA 2020
  • Kucherenko Lyudmila Ivanovna
  • Seminozhenko Vladimir Petrovich
  • Belenichev Igor Fedorovich
  • Khromyleva Olga Vladimirovna
RU2748035C1

RU 2 496 495 C2

Authors

Solov'Eva Ol'Ga Aleksandrovna

Storozheva Zinaida Ivanovna

Sherstnev Vladimir Vjacheslavovich

Bolotin Valerij Vladimirovich

Dates

2013-10-27Published

2011-12-05Filed